Abeona therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4)

New york and cleveland, april 21, 2020 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced it granted options to brian pereira, m.d., the newly-appointed executive chairman of the company, to purchase 930,000 shares of abeona common stock. the stock options have a $2.50 exercise price per share, which is equal to the closing price of abeona's common stock on the grant date. the options were offered as a material inducement to dr. pereira’s appointment as executive chairman.
ABEO Ratings Summary
ABEO Quant Ranking